High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Amyloid β‐protein (Aβ) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, high MW (HMW) aggregates such as protofibrils, and ultimately fibrils. These Aβ species can generally form amyloid plaques implicated in the neurodegeneration of Alzheimer disease (AD), but therapies designed to reduce plaque load have not demonstrated clinical efficacy. Recent evidence implicates amyloid oligomers in AD neuropathology, but the precise mechanisms are uncertain. We examined the mechanisms of neuronal dysfunction from HMW‐Aβ 1‐42 exposure by measuring membrane integrity, reactive oxygen species (ROS) generation, membrane lipid peroxidation, membrane fluidity, intracellular calcium regulation, passive membrane electrophysiological properties, and long‐term potentiation (LTP). HMW‐Aβ 1‐42 disturbed membrane integrity by inducing ROS generation and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation, depolarization, and impaired LTP. The damaging effects of HMW‐Aβ 1‐42 were significantly greater than those of LMW‐Aβ 1‐42 Therapeutic reduction of HMW‐Aβ 1‐42 may prevent AD progression by ameliorating direct neuronal membrane damage.—Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., Ono, K. High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage. FASEB J. 33, 9220–9234 (2019). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 2×
“Human genetic association studies, biochemical analyses of AD plaque content, and various animal models with altered Ab or tau expression strongly implicate Ab and tau inADpathogenesis (1).”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209
Self-citationEvidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Self-citationNakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., et al. (2014) · Scientific Reports · doi:10.1038/srep03594 · Cited by 673 · cited 8×
“We performed tapping mode high-speed atomic force microscopy (HS-AFM) (25, 26) at room temperature in liquid using a small cantilever (BL-AC10-DS; Olympus, Tokyo, Japan) with HMW AMYLOID b1-42 OLIGOMERS INDUCE NEUROTOXICITY 9221 resonance frequency f of 400–500 kHz and a spring constant k of 0.1 N/m.”
MethodInfluentialReactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
Massaad, C. A., & Klann, E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3208 · Cited by 635
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Oxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605 · cited 1×
“Along with the direct destruction/ modification of lipids, DNA and proteins, the byproducts of lipid peroxidation produced during oxidative stress cause damage to the mitochondria and up-regulate tau phosphorylation, which appears essential for NFT formation (42).”
Background
Cited by
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
Plasma membrane integrity in health and disease: significance and therapeutic potential
Dias, C., & Nylandsted, J. (2021) · Cell Discovery · doi:10.1038/s41421-020-00233-2 · Cited by 278
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia
Lučiūnaitė, A., McManus, R. M., Jankunec, M., Rácz, I., Dansokho, C., Dalgėdienė, I., Schwartz, S., Brosseron, F., & Heneka, M. T. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14945 · Cited by 192
“There are several studies that have shown both natural and synthetic Aβ oligomers exert neurotoxic effects in vitro (Yang et al., 2017; Yasumoto et al., 2019).”
BackgroundMembrane interaction to intercellular spread of pathology in Alzheimer’s disease
Valappil, D. K., Mini, N. J., Dilna, A., & Nath, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.936897 · Cited by 19
“Oligomers induce a toxic cascade involving PM damage (Yasumoto et al., 2019), lipid oxidation, ion-permeable membrane pores, as a result of which internalization takes place in the vesicles of endolysosomal pathways (Sengupta et al.”
BackgroundProtein Interactome of Amyloid-β as a Therapeutic Target
Lazarev, V. F., Dutysheva, E. A., Kanunikov, I. E., Guzhova, I. V., & Margulis, B. A. (2023) · Pharmaceuticals · doi:10.3390/ph16020312 · Cited by 9
“reported that protofibrils induce reactive oxygen species generation, lipid peroxidation, leading to calcium dysregulation, and the depolarization of iPSC-generated human cortical neuron plasma membrane [27].”
Background
Metadata
- Authors
- Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., & Ono, K.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2019-05-13
- Volume
- 33
- Issue
- 8
- Pages
- 9220-9234
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2945723821
- Cited by
- 120
- References
- 14
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage. https://app.cochat.ai/papers/10.1096/fj.201900604r
- The paper
- Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., & Ono, K. (2019). High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage. The FASEB Journal. https://doi.org/10.1096/fj.201900604r
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.